Akito Nishida

1.1k total citations
43 papers, 951 citations indexed

About

Akito Nishida is a scholar working on Surgery, Cellular and Molecular Neuroscience and Gastroenterology. According to data from OpenAlex, Akito Nishida has authored 43 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 16 papers in Cellular and Molecular Neuroscience and 13 papers in Gastroenterology. Recurrent topics in Akito Nishida's work include Helicobacter pylori-related gastroenterology studies (19 papers), Neuropeptides and Animal Physiology (14 papers) and Gastrointestinal motility and disorders (12 papers). Akito Nishida is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (19 papers), Neuropeptides and Animal Physiology (14 papers) and Gastrointestinal motility and disorders (12 papers). Akito Nishida collaborates with scholars based in Japan, United Kingdom and United States. Akito Nishida's co-authors include Takeshi Kamato, Hidenobu Yuki, Michiyo Yamano, Rie Tsutsumi, Shinobu Akuzawa, K Miyata, Hiroyuki Ito, Mitsuaki Ohta, Keiji Miyata and Yoshinori Katsuyama and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Medicinal Chemistry.

In The Last Decade

Akito Nishida

42 papers receiving 894 citations

Peers

Akito Nishida
Akito Nishida
Citations per year, relative to Akito Nishida Akito Nishida (= 1×) peers Takeshi Kamato

Countries citing papers authored by Akito Nishida

Since Specialization
Citations

This map shows the geographic impact of Akito Nishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akito Nishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akito Nishida more than expected).

Fields of papers citing papers by Akito Nishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akito Nishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akito Nishida. The network helps show where Akito Nishida may publish in the future.

Co-authorship network of co-authors of Akito Nishida

This figure shows the co-authorship network connecting the top 25 collaborators of Akito Nishida. A scholar is included among the top collaborators of Akito Nishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akito Nishida. Akito Nishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nishida, Akito, et al.. (2017). Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea. BioPsychoSocial Medicine. 11(1). 7–7. 8 indexed citations
3.
Delgado‐Herrera, Leticia, et al.. (2016). Cultural adaptation: translatability assessment and linguistic validation of the patient-reported outcome instrument for irritable bowel syndrome with diarrhea. SHILAP Revista de lepidopterología. 7. 81–81. 2 indexed citations
4.
Marquis, Patrick, Kathryn Lasch, Leticia Delgado‐Herrera, et al.. (2014). Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome. Clinical and Translational Gastroenterology. 5(6). e59–e59. 14 indexed citations
5.
Kadokura, Takeshi, et al.. (2008). The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects. European Journal of Clinical Pharmacology. 64(7). 691–695. 8 indexed citations
6.
Kadokura, Takeshi, et al.. (2008). The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects. European Journal of Clinical Pharmacology. 64(6). 605–609. 5 indexed citations
7.
Yuki, Hidenobu, Akito Nishida, Shinobu Akuzawa, et al.. (1997). YF476 is a new potent and selective gastrin/cholecystokinin‐B receptor antagonist in vitro and in vivo. Alimentary Pharmacology & Therapeutics. 11(1). 113–120. 56 indexed citations
8.
Nishida, Akito, et al.. (1997). Pharmacokinetic and pharmacodynamic evaluation of central effect of the novel antiallergic agent betotastine besilate.. PubMed. 47(10). 1116–24. 40 indexed citations
9.
Nagakura, Yukinori, et al.. (1996). Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs. Naunyn-Schmiedeberg s Archives of Pharmacology. 353(5). 489–98. 29 indexed citations
10.
Okamoto, Yoshinori, Hiroyuki Koshio, Mitsuaki Ohta, et al.. (1996). Biological Activity of Analogues of YM022. Novel (3-Amino Substituted Phenyl)urea Derivatives of 1,4-Benzodiazepin-2-one as Gastrin/Cholecystokinin-B Receptor Antagonists.. Chemical and Pharmaceutical Bulletin. 44(7). 1412–1414. 4 indexed citations
11.
Nishida, Akito, et al.. (1996). Comparative Evaluation of the Role of Endogenous Gastrin in Basal Acid Secretion in Conscious Rats Provided with Chronic Fistula and Pylorus Ligation. The Japanese Journal of Pharmacology. 71(3). 223–230. 9 indexed citations
12.
Ito, Hiroyuki, Shinobu Akuzawa, Rie Tsutsumi, et al.. (1995). Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex. Neuropharmacology. 34(6). 631–637. 32 indexed citations
13.
Miyata, Keiji, Takeshi Kamato, Akito Nishida, Kenji Takizawa, & Masaaki Takeda. (1995). Gastric mucosal protection by YM638, a novel leukotriene D4 receptor antagonist, in rats. European Journal of Pharmacology. 276(1-2). 165–175. 2 indexed citations
14.
Yamano, Mayumi, Takeshi Kamato, Akito Nishida, et al.. (1994). Serotonin (5-HT)3-Receptor Antagonism of 4,5,6,7-Tetrahydrobenzimidazole Derivatives against 5-HT-Induced Bradycardia in Anesthetized Rats.. The Japanese Journal of Pharmacology. 65(3). 241–248. 35 indexed citations
15.
Saita, Yuji, et al.. (1994). Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization. European Journal of Pharmacology Molecular Pharmacology. 269(2). 249–254. 31 indexed citations
16.
Yamano, Mayumi, et al.. (1993). Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation. European Journal of Pharmacology. 250(2). 303–310. 21 indexed citations
17.
Miyata, K, Takeshi Kamato, Akito Nishida, et al.. (1992). Role of the serotonin3 receptor in stress-induced defecation.. Journal of Pharmacology and Experimental Therapeutics. 261(1). 297–303. 104 indexed citations
18.
Miyata, K, Takeshi Kamato, Michiyo Yamano, et al.. (1991). Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats.. Journal of Pharmacology and Experimental Therapeutics. 259(2). 815–819. 34 indexed citations
19.
Miyata, Keiji, Takeshi Kamato, Akito Nishida, & Kazuo Honda. (1991). Studies on the mechanism for the gastric mucosal protection by famotidine in rats.. The Japanese Journal of Pharmacology. 55(2). 211–222. 12 indexed citations
20.
Hashizume, Takeshi, et al.. (1979). Protective effect of cetraxate, a new antiulcer drug, against serotonin-induced ulcer.. PubMed. 240(2). 314–27. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026